Fahad Alzahrani
About Fahad Alzahrani
Fahad Alzahrani is the Regulatory Lead and Scientific Office Manager at Bristol-Myers Squibb, with previous experience at Abbott and the Saudi Food & Drug Authority.
Current Role at Bristol-Myers Squibb
Fahad Alzahrani is the Regulatory Lead and Scientific Office Manager at Bristol-Myers Squibb. He has been with the company since April 2019. In this role, he is responsible for leading regulatory activities and managing scientific office operations. His work is critical to ensuring compliance with relevant regulations and standards, contributing to the company's mission in the pharmaceutical industry.
Previous Role at Abbott
Before joining Bristol-Myers Squibb, Fahad Alzahrani worked as a Regulatory Affairs Manager at Abbott. He served in this position for two years, from 2014 to 2016. In this role, he was integral in managing regulatory processes and ensuring that products met all necessary legal and regulatory requirements. His contributions helped streamline regulatory practices within the organization.
Positions at the Saudi Food & Drug Authority
Fahad Alzahrani has extensive experience with the Saudi Food & Drug Authority (SFDA), where he held multiple positions. He started as a Pharmacist from 2008 to 2009, then advanced to Senior Pharmacist in the Executive Directorate of Products Evaluation and Standards Setting from 2011 to 2013. He also coordinated the same directorate for a year from 2013 to 2014. In 2014, Fahad briefly served as the Acting Head of Pharmaceutical Raw Materials for five months. His diverse roles at SFDA provided him with a broad understanding of pharmaceutical regulations and standards.
Educational Background
Fahad Alzahrani has a strong educational background in pharmacy. He earned his Bachelor's degree from King Saud University, where he studied from 2003 to 2008. He furthered his education by obtaining a Master's degree from the University of Tasmania, where he studied from 2010 to 2011. His academic qualifications have provided a solid foundation for his career in regulatory affairs and pharmaceutical management.